Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Micronized Progesterone vs LNG-IUS for Non-atypical Endometrial Hyperplasia
NCT03992937Completed
- Sponsor
- Kocaeli University
- Start
- Jun 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of progesterone in Endometrial Hyperplasia Without Atypia (EH) (2 arms), sponsored by Kocaeli University. Primary endpoint: Regression and remission rate of endometrial hyperplasia at 3 months. Started Jun 2019; status: completed.
02
Drugs
progesterone
03
Conditions
Endometrial Hyperplasia Without Atypia (EH)
Beyond the preview
Go deeper on NCT03992937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03992937.